Browse Guides  internal medicine  haematology  anticoagulation

Warfarin

Starting treatment
Indications
Dosing and monitoring
Complications
Follow-up
Indications

If warfarin is contraindicated, consider long-term subcutaneous heparin d or LMWH d

Why?

  • Both are probably as effective as warfarin for long-term anticoagulation of patients with deep vein thrombosis. d
  • There is less bleeding in heparin than warfarin. a
  • However patients are at risk of osteopenia and thrombocytopenia on longterm heparin or LMWH, though there are fewer vertebral fractures on LMWH a

Long-term heparin causes fewer bleeds than warfarin, but vertebral fractures are common

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
proximal DVT a subcutaneous heparin warfarin any bleed
at 12 weeks
17% 89%
(15% to 99%)
7
(4 to 23)
venous thromboembolism a fragmin heparin vertebral fracture
at 6 months
15% 83%
(3% to 100%)
8
(4 to 240)

Expiry date: May 2003
Levels of Evidence used in grading these guides

With thanks to Drs. David Keeling, John Reynolds, David Sackett, Sharon Straus and Alan Townsend 
for use of their anticoagulation guide on which this one is based.

Author   CM   Ball
Reviewer   A   Gallus
CAT Writer   CM   Ball